Dacarbazine and lower respiratory tract infection Patient Reports February 11, 2012

Dacarbazine Side Effects Report #5066534-4
Dacarbazine side effect was reported by a Physician from SWITZERLAND on July 20, 2006. Female patient, 79 years of age, weighting 191.8 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: abdominal pain lower, activities of daily living impaired, anxiety , dyspnoea, lower respiratory tract infection, metastases to bone, metastases to lung, productive cough. Dacarbazine dosage: unknown. During the same period patient was treated with BOSENTAN, PREDNISOLONE, ALPRAZOLAM, AMITRIPTYLINE, RANITIDINE, TEMAZEPAM, ENDONE, PRAVACHOL. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5069554-9
Dacarbazine side effect was reported by a Physician from SWITZERLAND on July 20, 2006. Female patient, 79 years of age, weighting 191.8 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: abdominal pain lower, activities of daily living impaired, anxiety , dyspnoea, lower respiratory tract infection, metastases to bone, metastases to lung, productive cough. Dacarbazine dosage: unknown. During the same period patient was treated with BOSENTAN, PREDNISOLONE, ALPRAZOLAM, AMITRIPTYLINE, RANITIDINE, TEMAZEPAM, ENDONE, PRAVACHOL. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5076113-0
Dacarbazine side effect was reported by a Physician from AUSTRALIA on July 26, 2006. Female patient, 78 years of age, weighting 191.8 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: abdominal pain lower, anxiety , bacillus infection, back pain , bacterial infection , cough, dyspnoea, lower respiratory tract infection, metastases to bone. Dacarbazine dosage: 850 MG/M2 IV. During the same period patient was treated with PREDNISOLONE, ALPRAZOLAM, AMITRIPTYLINE, RANITIDINE, TEMAZEPAM, ENDONE, PRAVACHOL. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5076249-4
Dacarbazine side effect was reported by a Consumer or non-health professional from AUSTRALIA on July 20, 2006. Female patient, 78 years of age, weighting 191.8 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: abdominal pain lower, activities of daily living impaired, anxiety , back pain , bacterial infection , cough, dyspnoea, lower respiratory tract infection, metastases to bone. Dacarbazine dosage: 850 MG/M2, INTRAVENOUS. During the same period patient was treated with BOSENTAN, PREDNISOLONE, ALPRAZOLAM, AMITRIPTYLINE, RANITIDINE, TEMAZEPAM, ENDONE, PRAVACHOL. Patient was hospitalized. Patient recovered.


Dacarbazine Side Effects Report #5062495-2
Dacarbazine side effect was reported by a Physician from AUSTRALIA on July 18, 2006. Male patient, 76 years of age, weighting 180.8 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: lower respiratory tract infection, platelet count increased. Dacarbazine dosage: 2000 MG IV. During the same period patient was treated with BOSENTAN, ASPIRIN, COVERSYL, SIMVASTATIN, ESOMEPRAZOLE MAGNESIUM, THYROXINE, TEMAZEPAM, TIMOLOL MALEATE. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5062839-1
Dacarbazine side effect was reported by a Consumer or non-health professional from AUSTRALIA on July 17, 2006. Male patient, 76 years of age, weighting 180.8 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: lower respiratory tract infection, platelet count increased. Dacarbazine dosage: 2000 MG, TOTAL DAILY, INTRAVENOUS. During the same period patient was treated with ASPIRIN, PERINDOPRIL ERBUMINE, SIMVASTATIN, THYROXINE, TEMAZEPAM, TIMOLOL MALEATE, LATANOPROST. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5079776-9
Dacarbazine side effect was reported by a Consumer or non-health professional from SWITZERLAND on July 17, 2006. Male patient, 76 years of age, weighting 180.8 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: blood culture positive, lower respiratory tract infection, platelet count increased, staphylococcal infection . Dacarbazine dosage: unknown. During the same period patient was treated with ASPIRIN, COVERSYL, SIMVASTATIN, THYROXINE, TEMAZEPAM, TIMOLOL MALEATE, LATANOPROST. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5086066-7
Dacarbazine side effect was reported by a Physician from AUSTRALIA on Aug 11, 2006. Male patient, 76 years of age, weighting 180.8 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: bacteria blood identified, laboratory test interference, lower respiratory tract infection, platelet count increased, staphylococcal infection . Dacarbazine dosage: 2000 MG IV. During the same period patient was treated with BOSENTAN, ASPIRIN, COVERSYL, SIMVASTATIN, ESOMEPRAZOLE MAGNESIUM, THYROXINE, TEMAZEPAM, TIMOLOL MALEATE. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5167476-6
Dacarbazine side effect was reported by a Physician from AUSTRALIA on Nov 15, 2006. Male patient, 76 years of age, weighting 180.8 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: blood culture positive, lower respiratory tract infection, platelet count increased, staphylococcal infection . Dacarbazine dosage: 2000 MG IV. During the same period patient was treated with BOSENTIN, ASPIRIN, PERINDOPRIL ERBUMINE, SIMVASTATIN, ESOMEPRAZOLE MAGNESIUM, LEVOTHYROXINE, TEMAZEPAM, TIMOLOL MALEATE. Patient recovered.